PROSC regulates PLP availability by balancing its distribution to apoenzymes and preventing toxic accumulation. Key studies highlight:
PLP Supply and Detoxification: PROSC facilitates PLP delivery to enzymes like γ-aminobutyric acid (GABA) transaminase and aromatic L-amino acid decarboxylase (AADC), which require PLP as a cofactor .
E. coli Models: Deletion of the PROSC homolog (ΔYggS) in E. coli causes pyridoxine sensitivity, while human PROSC restores viability . Mutant variants (e.g., p.Leu175Pro, p.Arg241Gln) fail to complement this defect .
Vitamin B6-Dependent Epilepsy: Biallelic mutations in PLPBP (e.g., p.Ser78Ter, p.Arg241Gln) disrupt PLP homeostasis, leading to seizures and altered neurotransmitter profiles. Pre-treatment cerebrospinal fluid (CSF) shows low PLP, while fibroblasts accumulate excess PLP .
Genetic Variants: Four patients with PLPBP mutations (3 novel variants) were identified in a cohort of 700 with epileptic encephalopathies, highlighting its role in developmental disorders .
Studies suggest that PLPBP mutations impair PLP distribution, causing deficiency in neuronal tissues while leading to cytoplasmic overload .
SDS-PAGE Validation: Recombinant PROSC Human is validated via SDS-PAGE under reducing conditions, showing a single band at ~32.7 kDa .
Functional Assays: Used to study PLP-dependent enzyme activity in vitro and in cellular models .
The human PROSC gene is located on chromosome 8p11.2. It spans approximately 17kb of genomic DNA and contains 8 exons. The cDNA is 2530bp long with an open reading frame of 825bp, encoding a protein of 275 amino acids. The gene has been highly conserved throughout evolution, from bacteria to mammals, suggesting its critical functional importance . When studying this gene, researchers should consider using genome browsers like UCSC or Ensembl to visualize the exact chromosomal coordinates and genetic neighborhood, as these relationships may provide insights into regulatory mechanisms and evolutionary significance.
PROSC demonstrates ubiquitous expression across human tissues , indicating its fundamental role in cellular function. When investigating tissue-specific expression patterns, researchers should employ multiple methodologies:
RT-qPCR for quantitative mRNA expression analysis
Western blotting for protein expression confirmation
Immunohistochemistry for cellular and subcellular localization
Consider creating a comprehensive expression profile across different developmental stages and pathological conditions to understand contextual regulation of this gene.
PROSC is involved in the intracellular homeostatic regulation of pyridoxal 5'-phosphate (PLP), the active form of vitamin B6. It functions to supply this critical cofactor to apoenzymes while simultaneously minimizing potentially toxic side reactions . PLP itself serves as a cofactor for more than 140 enzymes in humans, many involved in neurotransmitter synthesis and degradation.
When studying PLP homeostasis, researchers should:
Measure intracellular PLP concentrations using HPLC or LC-MS/MS
Assess the activity of key PLP-dependent enzymes
Implement cellular models with PROSC knockout/knockdown to observe PLP dysregulation effects
Biallelic mutations in PROSC can cause pyridoxine-dependent epilepsy, characterized by seizures and other neurological symptoms that respond to pyridoxine (vitamin B6) or PLP supplementation . Pre-treatment cerebrospinal fluid samples from affected individuals typically show low PLP concentrations and reduced activity of PLP-dependent enzymes. Paradoxically, cultured fibroblasts from patients with PROSC mutations show excessive PLP accumulation .
Research approaches should include:
Comprehensive phenotyping of affected individuals
Metabolic profiling focusing on vitamin B6 pathway intermediates
Functional characterization of specific mutations using in vitro and in vivo models
When designing experiments to investigate PROSC function, consider these methodological approaches:
| Approach | Application | Advantages | Limitations |
|---|---|---|---|
| CRISPR/Cas9 gene editing | Creating cellular and animal models with PROSC mutations | Precise genetic modification, physiologically relevant | Off-target effects, potential developmental compensation |
| Recombinant protein expression | Biochemical characterization | Direct assessment of protein activity and binding | May not reflect in vivo complexity |
| Metabolomics | PLP and vitamin B6 pathway analysis | Comprehensive metabolite profiling | Requires specialized equipment, complex data interpretation |
| Patient-derived cells | Disease modeling | Direct relevance to human pathology | Variability between patient samples, limited availability |
| Bacterial complementation | Functional conservation studies | Simpler system for initial characterization | May not capture mammalian-specific interactions |
When implementing these approaches, prioritize experimental designs that allow for the assessment of both gain and loss of function, and consider the temporal dynamics of PROSC activity during development and under different cellular conditions .
Contradictions in experimental results, such as the observation that PROSC mutations lead to low CSF PLP levels but excessive PLP accumulation in fibroblasts , require systematic investigation. Such contradictions might reflect tissue-specific differences in PLP metabolism, subcellular compartmentalization, or compensatory mechanisms.
To address contradictory findings:
Perform parallel experiments in multiple model systems
Use complementary methodologies to validate observations
Consider temporal factors that might explain divergent results
Implement systems biology approaches to model complex interactions
Design experiments that specifically test competing hypotheses
Remember that contradictions often highlight opportunities for significant discoveries about complex biological systems .
Understanding the molecular basis of PROSC-PLP interactions requires sophisticated biochemical and biophysical techniques:
Isothermal Titration Calorimetry (ITC): Measures binding affinity and thermodynamic parameters
Surface Plasmon Resonance (SPR): Provides real-time binding kinetics
X-ray Crystallography: Reveals precise 3D structure of PROSC-PLP complexes
Nuclear Magnetic Resonance (NMR): Examines dynamic aspects of protein-ligand interactions
Molecular Dynamics Simulations: Models interaction dynamics in silico
When implementing these methods, consider how specific PROSC mutations might alter binding properties and how these alterations correlate with disease severity .
The high conservation of PROSC from bacteria to mammals provides a powerful framework for functional studies . The bacterial homolog YggS can serve as a model for understanding fundamental aspects of PROSC function.
Research strategies leveraging evolutionary conservation include:
Comparative genomics to identify absolutely conserved residues
Cross-species complementation studies (e.g., expressing human PROSC in ΔYggS E. coli strains)
Ancestral sequence reconstruction to infer functional evolution
Identification of co-evolved gene networks across species
Notably, complementation experiments with human PROSC have successfully restored growth in ΔYggS E. coli mutants, while disease-associated PROSC variants (p.Leu175Pro, p.Arg241Gln, and p.Ser78Ter) failed to complement, providing a valuable functional assay for variant pathogenicity assessment .
When conducting clinical research related to PROSC function, several biomarkers can provide insights into both normal function and pathological states:
| Biomarker | Sample Type | Clinical Relevance | Detection Method |
|---|---|---|---|
| PLP levels | CSF, plasma, erythrocytes | Direct indication of vitamin B6 metabolism | HPLC, LC-MS/MS |
| Activity of PLP-dependent enzymes | Blood, tissue samples | Functional impact of PLP dysregulation | Enzyme activity assays |
| Neurotransmitter metabolites | CSF, urine | Downstream effects on neural function | LC-MS/MS |
| PROSC protein levels | Blood cells, tissue biopsies | Expression analysis | Western blot, ELISA |
| PROSC gene variants | Blood, saliva | Genetic diagnosis | Next-generation sequencing |
These biomarkers should be evaluated in the context of clinical presentation, particularly in cases of suspected pyridoxine-dependent epilepsy or other neurological disorders potentially related to vitamin B6 metabolism .
When designing intervention studies for patients with PROSC mutations or related disorders, consider:
Dose-finding studies: Different forms of vitamin B6 (pyridoxine, pyridoxal, PLP) may have varying efficacy
Timing of intervention: Early intervention may prevent irreversible neurological damage
Combination therapies: Consider adjunctive treatments targeting specific downstream pathways
Biomarker monitoring: Regular assessment of PLP levels and enzyme activities
Long-term outcomes: Evaluate both seizure control and neurodevelopmental trajectories
Clinical trial designs should include appropriate controls and account for genetic heterogeneity, as different PROSC mutations may respond differently to interventions .
Several cutting-edge technologies hold promise for advancing our understanding of PROSC:
Single-cell omics: To understand cell-type-specific roles of PROSC
Spatial transcriptomics: To map PROSC expression in complex tissues like brain
Cryo-electron microscopy: For high-resolution structural analysis of PROSC-protein complexes
Organoid models: To study PROSC function in developmentally relevant 3D tissue contexts
Optogenetics/chemogenetics: For temporal control of PROSC activity in vivo
These technologies could help resolve existing contradictions in the literature and provide new insights into the complex role of PROSC in cellular homeostasis.
PROSC operates within complex metabolic and cellular networks. Systems biology approaches can help integrate diverse experimental data to develop comprehensive models of PROSC function:
Metabolic flux analysis: To understand how PROSC influences vitamin B6 metabolism dynamics
Protein-protein interaction networks: To identify PROSC binding partners and functional complexes
Multi-omics integration: To correlate genomic, transcriptomic, proteomic, and metabolomic data
Computational modeling: To predict the effects of PROSC variants on PLP homeostasis
Machine learning approaches: To identify patterns in complex datasets related to PROSC function
These approaches are particularly valuable for understanding how PROSC contributes to cellular resilience and how its dysfunction leads to disease .
The human recombinant PROSC protein is produced in Escherichia coli (E. coli) and is a single, non-glycosylated polypeptide chain containing 298 amino acids, including a 23 amino acid His-tag at the N-terminus . The molecular mass of this recombinant protein is approximately 32.7 kDa . The protein is typically formulated in a solution containing 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 10% glycerol, and 1mM DTT .
PROSC is a member of the UPF0001 family and plays a crucial role in cellular metabolism. It is involved in the binding and stabilization of pyridoxal phosphate (PLP), which is the active form of vitamin B6 . PLP is a vital cofactor for various enzymatic reactions, including amino acid metabolism, neurotransmitter synthesis, and hemoglobin production.
Recombinant PROSC protein is widely used in laboratory research to study its function and role in cellular metabolism. It is also used in structural biology studies to understand the protein’s interaction with PLP and other molecules. The recombinant protein is available in various quantities and is typically shipped with ice packs to maintain its stability .
For short-term storage, the PROSC protein should be kept at 4°C if it will be used within 2-4 weeks. For long-term storage, it is recommended to store the protein at -20°C with the addition of a carrier protein such as 0.1% HSA or BSA to prevent degradation . It is important to avoid multiple freeze-thaw cycles to maintain the protein’s integrity.